School of Population Health, University of Auckland, The University of Auckland Faculty of Medical and Health Sciences, Auckland, New Zealand.
School of Population Health, University of Auckland, The University of Auckland Faculty of Medical and Health Sciences, Auckland, New Zealand
BMJ Open Diabetes Res Care. 2023 Feb;11(1). doi: 10.1136/bmjdrc-2022-003140.
Evidence is still emerging on the relationships of arterial stiffness with cardiac autonomic neuropathy (CAN) and peripheral neuropathy (PN). To our knowledge no systematic reviews or meta-analyses of these associations have been published. The purpose of our review was to assess the association of arterial stiffness with each type of neuropathy. Medline and Embase were systematically searched for observational studies of arterial stiffness and neuropathy.The systematic review of 60 studies (25 for CAN and 37 for PN), 59 including people with diabetes, showed arterial stiffness overall was higher in people with neuropathy than people without neuropathy. Forty-three studies were included in the meta-analysis. For CAN (19 studies), arterial stiffness was increased in people with neuropathy compared with without, as measured by pulse wave velocity (PWV) (mean difference: 1.32 m/s, 95% CI 0.82 to 1.81, p<0.00001), pulse pressure (PP) (mean difference: 6.25 mmHg, 95% CI 4.51 to 7.99, p<0.00001) or augmentation index (mean difference: 5.52%, 95% CI 3.46 to 7.58, p<0.0001). For PN (26 studies), arterial stiffness was increased in people with neuropathy compared with those without, as measured by PWV (mean difference: 1.22 m/s, 95% CI 0.87 to 1.58, p<0.00001) or PP (mean difference: 4.59 mmHg, 95% CI 2.96 to 6.22, p<0.00001). Only two cohort studies were located so the temporality of the association between arterial stiffness and neuropathy remains unclear. Increased arterial stiffness is associated with CAN and PN.PROSPERO registration number: CRD42019129563.
目前仍有证据表明,动脉僵硬与心脏自主神经病变(CAN)和周围神经病变(PN)之间存在关联。据我们所知,尚未发表过关于这些关联的系统评价或荟萃分析。我们的综述旨在评估动脉僵硬与每种神经病变类型的关系。我们系统地检索了 Medline 和 Embase 中关于动脉僵硬和神经病变的观察性研究。对 60 项研究(25 项用于 CAN,37 项用于 PN)的系统综述,其中 59 项研究包括糖尿病患者,结果表明,患有神经病变的患者的动脉僵硬总体高于没有神经病变的患者。43 项研究被纳入荟萃分析。对于 CAN(19 项研究),与无神经病变的患者相比,患有神经病变的患者的动脉僵硬程度更高,这通过脉搏波速度(PWV)(平均差异:1.32m/s,95%CI 0.82 至 1.81,p<0.00001)、脉搏压(PP)(平均差异:6.25mmHg,95%CI 4.51 至 7.99,p<0.00001)或增强指数(平均差异:5.52%,95%CI 3.46 至 7.58,p<0.0001)来衡量。对于 PN(26 项研究),与无神经病变的患者相比,患有神经病变的患者的动脉僵硬程度更高,这通过 PWV(平均差异:1.22m/s,95%CI 0.87 至 1.58,p<0.00001)或 PP(平均差异:4.59mmHg,95%CI 2.96 至 6.22,p<0.00001)来衡量。仅找到了两项队列研究,因此动脉僵硬与神经病变之间的关联的时间顺序尚不清楚。动脉僵硬与 CAN 和 PN 相关。PROSPERO 注册号:CRD42019129563。
BMJ Open Diabetes Res Care. 2023-2
Nutr Metab Cardiovasc Dis. 2015-11
J Diabetes Complications. 2017-7-27
J Am Heart Assoc. 2017-12-21
Diabetes Metab Res Rev. 2022-9
J Clin Hypertens (Greenwich). 2020-12
Probl Endokrinol (Mosk). 2024-4-24
BMJ Open Ophthalmol. 2025-1-23
BMC Endocr Disord. 2021-2-23
BMJ Open Diabetes Res Care. 2020-3
J Clin Endocrinol Metab. 2019-7-1
BMC Neurol. 2018-8-27